Evaluation Approach Can Significantly Influence Oral Glucose-Lowering Drugs Total Mortality Risks in Retrospective Cohorts of Type 2 Diabetes Mellitus Patients

Current Diabetes Reviews - United Arab Emirates
doi 10.2174/1573399810666141021120951
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Understanding Patients With Type 2 Diabetes Mellitus Using Oral Antidiabetic Drugs

Journal of Medicine and Health
2020English

Effects of Intensive Glucose Lowering in Type 2 Diabetes

Yearbook of Endocrinology
2009English

Role of Conventional Oral Antidiabetic Drugs in Management of Type 2 Diabetes Mellitus

International Journal of Research in Medical Sciences
2017English

Lowering Low-Density Lipoprotein Cholesterol Levels in Patients With Type 2 Diabetes Mellitus

International Journal of General Medicine
Medicine
2014English

Blood Glucose-Lowering Therapy in Adults With Type 2 Diabetes

Nurse Prescribing
2016English

Glucose-Lowering Therapies for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: State-Of-The-Art Review

Mayo Clinic Proceedings
Medicine
2018English

Evaluation of Testosterone Deficiency in Patients of Type 2 Diabetes Mellitus

Journal of Evolution of Medical and Dental Sciences
2016English

Trend of Cost of Newer Glucose-Lowering Agents in Patients With Type 2 Diabetes Mellitus: Evidence From a Medical System in Taiwan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Evaluation of Parotid Salivary Glucose Level for Clinical Diagnosis and Monitoring Type 2 Diabetes Mellitus Patients

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy